Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) EVP Mark Stephen Katz sold 14,790 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the completion of the transaction, the executive vice president now owns 12,386 shares in the company, valued at $884,236.54. The trade was a 54.42 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.
Ryan Specialty Stock Performance
Shares of RYAN opened at $70.88 on Friday. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The stock has a market cap of $18.56 billion, a P/E ratio of 92.05, a P/E/G ratio of 1.63 and a beta of 0.62. The business’s 50 day moving average price is $68.14 and its 200-day moving average price is $61.66. Ryan Specialty Holdings, Inc. has a 52 week low of $41.49 and a 52 week high of $73.10.
Ryan Specialty (NYSE:RYAN – Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting analysts’ consensus estimates of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The firm had revenue of $604.69 million for the quarter, compared to analysts’ expectations of $602.04 million. During the same period in the prior year, the firm posted $0.32 earnings per share. The company’s quarterly revenue was up 20.5% on a year-over-year basis. Equities research analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current fiscal year.
Ryan Specialty Announces Dividend
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in RYAN. Hollencrest Capital Management bought a new stake in shares of Ryan Specialty during the third quarter valued at approximately $25,000. Assetmark Inc. bought a new stake in shares of Ryan Specialty in the 3rd quarter worth $34,000. GAMMA Investing LLC raised its stake in shares of Ryan Specialty by 96.4% in the second quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock worth $35,000 after purchasing an additional 297 shares during the last quarter. Crewe Advisors LLC purchased a new position in shares of Ryan Specialty in the second quarter worth $39,000. Finally, Signaturefd LLC lifted its holdings in shares of Ryan Specialty by 12.3% during the third quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock valued at $89,000 after purchasing an additional 148 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.
Wall Street Analyst Weigh In
RYAN has been the topic of a number of research analyst reports. Wells Fargo & Company boosted their price target on Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a report on Thursday, October 10th. UBS Group raised their price target on Ryan Specialty from $67.00 to $76.00 and gave the stock a “buy” rating in a research note on Tuesday, August 13th. JPMorgan Chase & Co. boosted their price objective on shares of Ryan Specialty from $54.00 to $56.00 and gave the company an “underweight” rating in a research report on Friday, August 2nd. BMO Capital Markets raised shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $65.00 to $75.00 in a research report on Tuesday, September 24th. Finally, Citigroup boosted their price target on shares of Ryan Specialty from $56.00 to $62.00 and gave the company a “neutral” rating in a research report on Tuesday, July 23rd. One research analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $70.33.
Read Our Latest Stock Analysis on RYAN
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Further Reading
- Five stocks we like better than Ryan Specialty
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Following Congress Stock Trades
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- 3 REITs to Buy and Hold for the Long Term
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.